Business
AstraZeneca advice unlikely to change despite rate of rare clotting ‘doubling’ – Sydney Morning Herald
New European research suggests the incidence of a rare blood clotting condition in AstraZeneca vaccine recipients is twice as prevalent as previously reported,…
Professor Cheng said incidence of cases reported from Europe was still a pretty small number and possibly a result of doctors getting better at detecting the condition, which has a fatality rate of about one in four cases.
Im sure very early on, before anyone realised what this was, people thought it was just an unusual clot there may have been some that flew under the radar, he said.
ATAGI issued an advisory in early April recommending people under 50 receive the Pfizer vaccine ahead of the AstraZeneca…
-
General19 hours agoFrom jackaroo to ‘Golden Tonsils’ radio titan: the life and career of John Laws
-
General23 hours agoMajority of Australia’s first Ashes Test squad to feature in Sheffield Shield round four
-
General6 hours agoPrincess Anne remembers Porepunkah police officers in wreath-laying ceremony in Melbourne
-
General10 hours agoAFL gives teams finishing 10th chance to win premiership through wildcard round in finals